Xembify

Xembify (Human Normal Immunoglobulin) is a sterile, liquid immunoglobulin therapy for subcutaneous use. It supports immune function in patients with primary immunodeficiency. This product is derived from human plasma and processed for safety. Ideal for home administration under medical supervision.

Xembify is used to treat primary immunodeficiency diseases, where the body lacks sufficient antibodies. It helps reduce the frequency of infections by providing passive immunity. Patients with conditions like common variable immunodeficiency or X-linked agammaglobulinemia benefit from regular infusions. It is also used for maintenance therapy in autoimmune disorders.

Xembify provides antibodies that help the immune system fight infections. Patients may experience improved energy levels and fewer illness episodes over time. Some users report better overall health and reduced reliance on antibiotics. The effects vary based on individual immune needs and treatment consistency.

Store Xembify in a refrigerator at 2°C to 8°C (36°F to 46°F) and protect it from light. Do not freeze or shake the vial. Always check the solution for particles or discoloration before use. Follow your healthcare provider’s instructions for proper handling and disposal.

Xembify may interact with live vaccines, reducing their effectiveness. Avoid receiving live vaccines within 3 months before or after treatment. Inform your doctor about all medications, including over-the-counter drugs and supplements. Blood tests may be needed to monitor interactions.